The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance.
about
Interactions of Monoamine Oxidases with the Antiepileptic Drug Zonisamide: Specificity of Inhibition and Structure of the Human Monoamine Oxidase B ComplexT-type calcium channel blockers as neuroprotective agents.Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders.Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's diseaseSystemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell-derived dopaminergic neurons.Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's diseaseComputational Drug Target Screening through Protein Interaction Profiles.Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injuryNeuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.Protective effects of zonisamide against rotenone-induced neurotoxicity.Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro.Changes of MAO-A and MAO-B Expressions in the Placenta of MPTP or MPP(+) Treated Mice.Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.Overcoming Obstacles to Drug Repositioning in Japan.Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease.Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease.Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized, double-blind phase 2 study.
P2860
Q27666365-B5829F6A-BAAB-44F1-A932-81012886954FQ30415535-E362896D-1F40-42CB-97D2-FE007A7DA5DDQ34472695-E6CCA73B-E98C-47F6-9E9F-F44EA612B268Q35106629-C8D843E1-8104-49DC-B872-41CD545B36F8Q36613561-F80A294B-7029-4AC1-92D2-5096619F3C4DQ37356891-4960F889-2112-409F-B75B-BAAD8D601D41Q37414273-18F409E0-EC0F-4E1B-9884-696A4591F3A2Q37739993-CC7CA4CC-B5B5-471D-B2DE-F3E3DACF1925Q38684428-2B4222F5-3413-49D9-9954-48E56D725E99Q39076196-FDFD713E-7385-4751-A275-8D0B9D765E95Q39634949-4980F6C5-7D02-4241-821D-B4935E3C8154Q39688860-1E7C92CF-8247-4707-A4ED-2A43A9EE9C06Q40420757-32E08BA4-7A7C-4163-BB02-AD671FC6AD0DQ42700223-1C612CE2-9AD3-43CD-85F5-B2E451AA5195Q45151001-2E06BBFE-6F91-4DDF-AC34-FEADA51DF163Q48238293-6E701169-213D-4821-8B84-9F2A7A65A1D1Q49788272-8B69D19F-DEE1-48F3-926C-86F17770FDB4
P2860
The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The antiepileptic drug zonisam ...... y in mice: clinical relevance.
@ast
The antiepileptic drug zonisam ...... y in mice: clinical relevance.
@en
type
label
The antiepileptic drug zonisam ...... y in mice: clinical relevance.
@ast
The antiepileptic drug zonisam ...... y in mice: clinical relevance.
@en
prefLabel
The antiepileptic drug zonisam ...... y in mice: clinical relevance.
@ast
The antiepileptic drug zonisam ...... y in mice: clinical relevance.
@en
P2093
P2860
P1476
The antiepileptic drug zonisam ...... y in mice: clinical relevance.
@en
P2093
Bozena Winnik
Brian Buckley
Lai-Yoong Wong
Patricia K Sonsalla
P2860
P304
P356
10.1016/J.EXPNEUROL.2009.11.018
P407
P577
2009-12-04T00:00:00Z